Ellevest Inc’s Xeris Biopharma Holdings XERS Stock Holding History

Ellevest Inc’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-47	Closed	–	–	1434
2021 Q1	$0	Hold	47	–	–	﹤0.01%	1369
2020 Q4	$0	Buy	+47	New	+$235	﹤0.01%	1378

Other funds holding XERS

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ellevest Inc's XERS Position: Q2 2021 in Review

Ellevest Inc sold out of Xeris Biopharma Holdings (XERS) in Q2 2021, closing a stake of 47 shares.

Ellevest Inc first reported a position in XERS in Q4 2020 and held it in 2 quarters. The position peaked at $0 in Q1 2021. 93 funds tracked by Wall St. Rank hold XERS as of Q2 2021.

Ellevest Inc reported no remaining Xeris Biopharma Holdings position as of Q2 2021 after selling out during the quarter.
Ellevest Inc sold 47 Xeris Biopharma Holdings shares in Q2 2021.
Ellevest Inc first reported a position in Xeris Biopharma Holdings in Q4 2020 and held it in 2 quarters.
Ellevest Inc's Xeris Biopharma Holdings position peaked at $0 in Q1 2021.
93 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2021.

Based on Ellevest Inc's 13F filing for Q2 2021, filed 13 Jul 2021.